Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.

FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
Reports on breast density inform women of their status but raise questions about what to do next.
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
Nearly half of cancer survivors report their treatment left them in debt.
Geriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.
Plant-based diets may help people with prostate cancer reduce their risk for disease progression.
Research suggests social activity is beneficial for cancer survivors’ longevity.
Journalist Lawrence Ingrassia traces the scientific history of a genetic disorder that predisposes families like his to cancer.
Talk with your provider before surgery and stay active to help prevent this side effect.